Colorectal Cancer

Colorectal Cancer

The Temple colorectal cancer team brings together the experience, technical proficiencies and deep multidisciplinary support needed to manage all aspects of care for high-risk patients with the most complex or challenging clinical situations.

Led by specialists in medical oncology, gastroenterology, surgery and radiation oncology, our team's principal goal is to eliminate cancerous cells at the primary tumor site and wherever they may have spread. We also aim to address comorbidities, minimize treatment side effects, maximize survival and patient quality of life, and preserve normal function without the need for a permanent colostomy.

All patients receive a comprehensive pretreatment workup, a customized plan for therapy and a program for follow-up and support.

Treatment options and services at Temple include:

  • Complex polpectomy
  • A state-of-the-art endoscopy center with full endoscopic ultrasound capability
  • Expertise in biopsy with tumor grading and staging
  • The latest chemotherapy drugs and targeted therapies
  • Advanced protocols of chemotherapy/radiation combinations
  • Board-certified colorectal surgeons with experience in sphincter-sparing techniques
  • Laparoscopic procedures
  • Colonic stents for obstructive colorectal tumors
  • Management of patients with inflammatory bowel disease
  • Alternative and palliative therapies
  • Education, counseling and support groups for patients and families

Temple Colorectal Cancer Team

Colorectal Surgery
Howard Ross, MD, FACS, FASCRS

Benjamin Krevsky, MD

Medical Oncology
Aruna Padmanabhan, MD

Oncologic Surgery
John Daly, MD, FACS

Radiation Oncology
Curtis Miyamoto, MD

Case Study from the Temple Digestive Disease Center

Determination plus Innovation in Managing the Most Complex Cases

Amilia D., 68, presented to a Temple gastroenterologist complaining of weight loss and severe cramping in her lower abdomen. A colonoscopy revealed a large lesion 15 cm from the anal verge that was completely obstructing her colon. Biopsies confirmed rectal adenocarcinoma and further tests dete cted two lesions on her liver.

Because this patient also had significant vascular comorbidities, a course of radiation and chemotherapy was initiated instead of immediate surgery. When the colon became completely obstructed, a colonic stent was placed. The decompression relieved the patient's symptoms but was not a durable solution for her malignant obstruction. Ultimately, additional interventions were needed and she underwent colonic resection with creation of an ileostomy in order to resume chemotherapy. Over the course of her two years of care at Temple, this patient with stage IV colorectal cancer has maintained a good quality of life despite complex underlying medical conditions and periodic setbacks in her condition. By constantly monitoring the patient's status and making frequent calculated adjustments in treatment, the multidisciplinary team was able to provide Amilia with the best possible outcome for the longest period of time.

For Referrals to the Colorectal Cancer Program

Physician to Physician Referrals: 215-707-5555